Drugmakers are lobbying US president Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and to allow time to shift manufacturing, ...
LONDON/NEW YORK (Reuters) -Drugmakers are lobbying U.S. President Donald Trump to phase in tariffs on imported pharmaceutical ...
Exclusive reporting on Munster, national and international business news and how it impacts Ireland and the poeple who live ...
Newsweek has created a map showing the European nations where governments and companies have rejected a U.S. directive ...
Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
12h
Drugmakers are lobbying President Trump to phase in tariffs on imported pharmaceutical products to alleviate the impact and ...
Drugmakers have argued that tariffs could increase the chance of drug shortages and reduce access for patients.
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc between February 5, 2020 and August 14, 2022, both dates inclusive (the ...
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback